⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2504997 | 1.00 | — | — | |
| SCHEMBL7515150 | 0.78 | — | — | |
| SCHEMBL7515146 | 0.78 | — | — | |
| SCHEMBL11804103 | 0.78 | — | — | |
| SCHEMBL2769728 | 0.75 | — | — | |
| SCHEMBL9237609 | 0.75 | — | — | |
| SCHEMBL2769730 | 0.75 | — | — | |
| SCHEMBL3838092 | 0.73 | — | — | |
| SCHEMBL3838089 | 0.73 | — | — | |
| SCHEMBL8082421 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8735624-B2 | Polymorphic form of CHDMAPP, method of preparation thereof, and pharmaceutical composition comprising same | INNATE PHARMA (FR) | 2014-05-27 | — | — | US | disclosed |
| EP-2324040-B1 | NOVEL POLYMORPHIC FORM OF CHDMAPP, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | INNATE PHARMA (FR) | 2014-01-01 | — | — | EP | disclosed |
| US-20110245534-A1 | NOVEL POLYMORPHIC FORM OF CHDMAPP, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | INNATE PHARMA (FR) | 2011-10-06 | — | — | US | disclosed |
| EP-2324040-A1 | NOVEL POLYMORPHIC FORM OF CHDMAPP, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Innate Pharma (FR) | 2011-05-25 | — | — | EP | disclosed |
| US-20100291118-A1 | Class of Gamma Delta T Cells Activators and Use Thereof | INNATE PHARMA (FR) | 2010-11-18 | — | — | US | disclosed |
| US-20100291118-A1 | Class of Gamma Delta T Cells Activators and Use Thereof | INNATE PHARMA (FR) | 2010-11-18 | — | — | US | disclosed |
| US-20100291118-A1 | Class of Gamma Delta T Cells Activators and Use Thereof | INNATE PHARMA (FR) | 2010-11-18 | — | — | US | disclosed |
| US-20100254940-A1 | Compositions and Methods for Regulating an Immune Response in a Subject | INNATE PHARMA, S.A. (FR) | 2010-10-07 | — | — | US | disclosed |
| US-20100222306-A1 | Class of Gamma Delta T Cells Activators and Use Thereof | INNATE PHARMA, S.A. (FR) | 2010-09-02 | — | — | US | disclosed |
| US-7767842-B2 | Class of γδ T cells activators and use thereof | INNATE PHARMA SA (FR) | 2010-08-03 | — | — | US | disclosed |
| US-20070134273-A1 | Composition and method for the treatment of carcinoma | ROMAGNE FRANCOIS | 2007-06-14 | — | — | US | disclosed |
| US-20070134273-A1 | Composition and method for the treatment of carcinoma | ROMAGNE FRANCOIS | 2007-06-14 | — | — | US | disclosed |
| EP-1761278-A1 | ADJUVANT COMPOSITION AND METHODS FOR ITS USE | Innate Pharma (FR) | 2007-03-14 | — | — | EP | disclosed |
| EP-1720567-A2 | COMPOSITION AND METHOD FOR THE TREATMENT OF CARCINOMA | Innate Pharma (FR) | 2006-11-15 | — | — | EP | disclosed |
| WO-2006103568-A2 | NEW CLASS OF Ϝδ T CELLS ACTIVATORS AND USE THEREOF | INNATE PHARMA (FR) | 2006-10-05 | — | — | WO | disclosed |
| US-20060194755-A1 | Compositions and methods for regulating an immune response in a subject | INNATE PHARMA, S.A.S. (FR) | 2006-08-31 | — | — | US | disclosed |
| WO-2005102385-A1 | ADJUVANT COMPOSITION AND METHODS FOR ITS USE | INNATE PHARMA (FR) | 2005-11-03 | — | — | WO | disclosed |
| EP-1569656-A2 | PHOSPHOANTIGENS FOR REGULATING AN IMMUNE RESPONSE | Innate Pharma (FR) | 2005-09-07 | — | — | EP | disclosed |
| WO-2005077411-A2 | COMPOSITION AND METHOD FOR THE TREATMENT OF CARCINOMA | INNATE PHARMA (FR) | 2005-08-25 | — | — | WO | disclosed |
| WO-2004050096-A2 | PHOSPHOANTIGENS FOR REGULATING AN IMMUNE RESPONSE | INNATE PHARMA (FR) | 2004-06-17 | — | — | WO | disclosed |